About Asia Pacific Liver Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Asia Pacific Liver Center
During the past decade, Asia Pacific Liver Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
2012-07-01
2013-05-01
Completed
354
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Asia Pacific Liver Center"
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Asia Pacific Liver Center
According to Clinical.Site data, the most researched conditions in "Asia Pacific Liver Center" are
"Chronic Hepatitis B" (4 trials), "Chronic HIV Infection" (1 trials), "Chronic Hepatitis D Infection With Hepatitis B" (1 trials), "HBV" (1 trials) and "Hepatitis Delta Virus" (1 trials). Many other conditions were trialed in "Asia Pacific Liver Center" in a lesser frequency.
Clinical Trials Intervention Types at Asia Pacific Liver Center
Most popular intervention types in "Asia Pacific Liver Center" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "ABI-H0731" (3 trials), "Placebo Oral Tablet" (2 trials), "TDF" (2 trials), "Lonafarnib" (1 trials) and "NrtI" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Asia Pacific Liver Center
The vast majority of trials in "Asia Pacific Liver Center" are
7 trials for "All" genders.
Clinical Trials Status at Asia Pacific Liver Center
Currently, there are NaN active trials in "Asia Pacific Liver Center".
1 are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Asia Pacific Liver Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Asia Pacific Liver Center, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".